Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Prevention Valuation: Fund Health, Not Just Sav...
By
Rene Pretorius
May 9, 2025
Prevention promises healthier lives, but how should we value it? Prevention valuation is critical for funding in value-based care systems. The proverb "
FDA AI Drug Approval
Implementing Health Technology Assessment in Oman
TAVR Asymptomatic Approval: A New Era for Early Intervention in Aortic Stenosis
Empowering Health: The Role of Self-Care and NCDs in Global Health Policy
Nipocalimab for Myasthenia Gravis Treatment
Journavx for Pain Management: Toward Affordability and Access
Optimizing Value-Based Drug Pricing in Japan with MARIE Framework
Targeting Shared Risk Pathways to Prevent Stroke, Dementia, and Depression
Navigating Drug Price Regulation: Evaluating the Executive Order’s Pote...
Capivasertib Cost-Effectiveness in Advanced Breast Cancer
Reserve Antibiotics Benefits: G-BA Designates Meropenem/Vaborbactam as Critic...
NICE Grants Conditional Robotic Surgery Approval to Enhance Patient Care and ...
« Previous
1
…
5
6
7
8
9
…
42
Next »